New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present ...

BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal. The report introduces two new diagnostic ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

A study shows GLP-1 weight-loss drugs reduce Alzheimer’s risk but increase arthritis, kidney, and pancreas issues.

Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...